Lund University
Alzheimer's Disease Studies Outline CSF, Blood Markers for Cognitive Symptoms, Tau Pathology
New research linked cognitive impairment symptoms to a synapse protein ratio in cerebrospinal fluid, while underscoring tauopathy ties to blood plasma levels of eMTBR-tau243.
New Blood Test Shows 90 Percent Accuracy in Diagnosing Alzheimer’s Disease
Developed by researchers from Lund University in Sweden, the test is more accurate than doctors’ diagnoses using standard clinical evaluation tools.
Qlucore Expands Into Bladder Cancer Diagnostics With Lund University Partnership
The company expects that this work to develop and validate classifier models for bladder cancer will lead to a CE mark for its Qlucore Diagnostics software platform.
The researchers used mass spec and data analytics to develop lipid profiles that predicted diabetes and cardiovascular disease risk in the distant future.
The approval of Biogen's Alzheimer's disease treatment in June was seen as an important regulatory development for companies developing tests.